Answers are grounded in this paper and cite their sources.
Immune checkpoint inhibitors are associated with a myriad of autoimmune adverse events. We present a 70-year-old patient with renal-cell carcinoma treated with nivolumab/ipilimumab complicated with myocarditis and encephalitis in which gradual impairment of the His-Purkinje system progressed to complete atrioventricular block. Full recovery was achieved after treatment with corticosteroids and immunoglobulins. (Level of Difficulty: Intermediate.)
No takes yet. Share an insight, caveat, or question.
Lorente-Ros et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: